These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5424533)

  • 1. Immunologic status of host and response of a methylcholanthrene-induced sarcoma to local x-irradiation.
    Suit HD; Kastelan A
    Cancer; 1970 Jul; 26(1):232-8. PubMed ID: 5424533
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 5. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 6. The fate of methylcholanthrene tumor cells in bone: analysis of immune factors in host resistance.
    McLaughlin AP; Kessler WO; Clark PL; Gittes RF
    J Surg Res; 1973 Mar; 14(3):186-92. PubMed ID: 4702159
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of anti-embryo immunization on methylcholanthrene-induced sarcoma growth in BALB/c mice.
    Parmiani G; Lembo R
    Int J Cancer; 1974 Oct; 14(4):555-64. PubMed ID: 4617712
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the spleen in the immunity to a chemically induced sarcoma in C3H mice.
    Bard DS; Pilch YH
    Cancer Res; 1969 May; 29(5):1125-31. PubMed ID: 5781103
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 15. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation-induced changes in established tumor immunity.
    Vaage J; Doroshow JH; DuBois TT
    Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453
    [No Abstract]   [Full Text] [Related]  

  • 17. [The immunopotentiating action of BCG and its various effects on tumors (author's transl)].
    Yamada H
    Kekkaku; 1978 Jan; 53(1):11-23. PubMed ID: 633697
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
    Simmons RL; Rios A; Ray PK
    J Surg Oncol; 1972; 4(4):298-305. PubMed ID: 5083567
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP; zbar B
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.